Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Palnox 0.25 mg Injection
Manufacturer/Marketed By : Glenmark Pharmaceuticals Ltd
$1.56 $1.07
Palnox 0.25 mg injection is a potent serotonin receptor antagonist designed to effectively prevent nausea and vomiting, particularly in patients undergoing chemotherapy or surgical procedures. This medication works by inhibiting...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Palonosetron 0.25 mg
Active Pharmaceutical Ingredient
Palnox 0.25 mg Injection
$1.56
$1.07
Palnox 0.25 mg injection is a potent serotonin receptor antagonist designed to effectively prevent nausea and vomiting, particularly in patients undergoing chemotherapy or surgical procedures. This medication works by inhibiting specific receptors in the brain that are responsible for triggering these unpleasant symptoms, making it an essential option for both adults and children. While Palnox is generally well-tolerated, users should be aware of potential side effects, which may include nausea, headache, dizziness, and gastrointestinal disturbances such as constipation or diarrhea. Additionally, there are important safety considerations, including the risk of QT prolongation and bradycardia, which necessitate careful monitoring during treatment. As with any medication, it's crucial to consult with a healthcare professional to discuss individual risks and benefits. Overall, Palnox 0.25 mg injection is a reliable choice for managing chemotherapy- or surgery-related nausea and vomiting, helping patients maintain a better quality of life during their treatment journey.
Active Pharmaceutical Ingredient
Uses
• Palnox 0 25 mg injection is primarily used to manage nausea and vomiting that can occur as a result of chemotherapy treatments. Patients undergoing chemotherapy often experience severe gastrointestinal side effects, making it difficult to maintain nutrition and hydration. By administering Palnox 0 25 mg injection, healthcare providers can help alleviate these distressing symptoms. This allows patients to focus more on their recovery process without the added burden of nausea.
• Another significant use of Palnox 0 25 mg injection is in the management of post-operative nausea and vomiting. After surgical procedures, many patients experience nausea, which can delay recovery and prolong hospital stays. The effective formulation of Palnox 0 25 mg injection targets these symptoms, providing relief and promoting a smoother recovery. This makes it an essential option for enhancing patient comfort in the post-operative setting.
• Palnox 0 25 mg injection is also beneficial for patients who may have a heightened risk of nausea due to specific medical conditions or treatments. It can be administered in various healthcare settings, including hospitals and outpatient clinics, to ensure patients receive timely relief. This versatility allows healthcare providers to effectively address nausea and vomiting in diverse patient populations. Overall, Palnox 0 25 mg injection serves as a critical tool in improving the quality of care for those experiencing these symptoms.
• In addition to its primary uses, Palnox 0 25 mg injection may be considered in cases where patients have previously experienced treatment-related nausea and vomiting. Healthcare professionals can use this medication to preemptively manage symptoms before they arise. This proactive approach is particularly valuable for patients who have had adverse reactions to similar treatments in the past. Palnox 0 25 mg injection thus plays a crucial role in individualized patient care plans.
Benefits
Palnox 0.25 mg Injection is a medicine that is mainly used to prevent nausea and vomiting caused by chemotherapy, especially in patients undergoing cancer treatment.Palnox Injection blocks the action of chemicals in the body that can make you feel or get sick. It is used in both adults and children to prevent nausea and vomiting associated with cancer treatment such as chemotherapy or radiotherapy. This medicine can help you to recover more easily from these types of treatment. {It is also used to prevent nausea and vomiting after an operation (only in adults). Palnox 0.25 mg Injection is injected by a doctor using the dose that is best for you, depending on the condition you are being treated for. Do not give yourself this medicine to avoid unwanted side effects.
Side Effects
Like all medicines, Palnox 0.25 mg Injection may cause side effects that do not require medical attention and which will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Itching
• Shivering
• Trembling or shaking
• Twitching
• Fever
• Headache
• Pain
• Redness
• Constipation
• Agitation
• Diarrhoea
• Lack of coordination
• Restlessness
Common Side Effects
• Breathing difficulty
• Confusion
• Comma ( loss of consciousness)
• Arrhythmias ( irregular heart beats)
• Lightheadedness
• Chest pain
• Rashes
How To Use
Palnox 0.25 mg Injection is given by a healthcare professional in a hospital or clinic setting. It is usually given 30 minutes before chemotherapy or just before you are given an anaesthetic for surgery. Do not administer this Palnox 0.25 yourself.
Safety Advice
• Alcohol: Drinking alcohol while taking Palnox 0.25 is generally not recommended. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol intake while taking any medication.
• Kidney: Palnox 0.25 mg Injection may consider safe to use in patients with kidney disease. There is no dose adjustment of Palnox 0.25 mg is recommended.
• Breastfeeding: It is probably safe to use Palnox 0.25 mg while you are breastfeeding. The limited data available in humans suggest that the drug does not pose a significant risk to the baby.
• Liver: Palnox 0.25 mg Injection may be considered safe to use in patients with liver disease. There is no dose adjustment of Palnox 0.25 mg is recommended.
• Pregnancy: In general, Palnox 0.25 mg Injection is safe to use during pregnancy. Animal studies have shown little or no harm to the developing baby, but there is limited research in humans.
• Driving: Palnox 0.25 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Palnox.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.